Literature DB >> 21308723

Assessment of evaluation criteria for survival prediction from genomic data.

Hege M Bøvelstad1, Ornulf Borgan.   

Abstract

Survival prediction from high-dimensional genomic data is dependent on a proper regularization method. With an increasing number of such methods proposed in the literature, comparative studies are called for and some have been performed. However, there is currently no consensus on which prediction assessment criterion should be used for time-to-event data. Without a firm knowledge about whether the choice of evaluation criterion may affect the conclusions made as to which regularization method performs best, these comparative studies may be of limited value. In this paper, four evaluation criteria are investigated: the log-rank test for two groups, the area under the time-dependent ROC curve (AUC), an R²-measure based on the Cox partial likelihood, and an R²-measure based on the Brier score. The criteria are compared according to how they rank six widely used regularization methods that are based on the Cox regression model, namely univariate selection, principal components regression (PCR), supervised PCR, partial least squares regression, ridge regression, and the lasso. Based on our application to three microarray gene expression data sets, we find that the results obtained from the widely used log-rank test deviate from the other three criteria studied. For future studies, where one also might want to include non-likelihood or non-model-based regularization methods, we argue in favor of AUC and the R²-measure based on the Brier score, as these do not suffer from the arbitrary splitting into two groups nor depend on the Cox partial likelihood.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Year:  2011        PMID: 21308723     DOI: 10.1002/bimj.201000048

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  9 in total

1.  Methylomic predictors demonstrate the role of NF-κB in old-age mortality and are unrelated to the aging-associated epigenetic drift.

Authors:  Juulia Jylhävä; Laura Kananen; Jani Raitanen; Saara Marttila; Tapio Nevalainen; Antti Hervonen; Marja Jylhä; Mikko Hurme
Journal:  Oncotarget       Date:  2016-04-12

2.  ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models.

Authors:  Letizia Astrologo; Eugenio Zoni; Sofia Karkampouna; Peter C Gray; Irena Klima; Joël Grosjean; Marie J Goumans; Lukas J A C Hawinkels; Gabri van der Pluijm; Martin Spahn; George N Thalmann; Peter Ten Dijke; Marianna Kruithof-de Julio
Journal:  Front Cell Dev Biol       Date:  2017-12-05

3.  NOD2 maybe a biomarker for the survival of kidney cancer patients.

Authors:  Deguo Xu; Shuisheng Zhang; Shenfeng Zhang; Hongmei Liu; Paiyun Li; Lili Yu; Heli Shang; Yong Hou; Yuan Tian
Journal:  Oncotarget       Date:  2017-10-06

Review 4.  GradientScanSurv-An exhaustive association test method for gene expression data with censored survival outcome.

Authors:  Ming Yi; Ruoqing Zhu; Robert M Stephens
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

5.  Hyper expression of MTBP may be an adverse signal for the survival of some malignant tumors: A data-based analysis and clinical observation.

Authors:  Yantao Mao; Mei Tian; Bo Pan; Qingshan Zhu; Paiyun Li; Hongmei Liu; Weipeng Liu; Ningtao Dai; Lili Yu; Yuan Tian
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

6.  Survival prediction based on compound covariate under Cox proportional hazard models.

Authors:  Takeshi Emura; Yi-Hau Chen; Hsuan-Yu Chen
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

7.  Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence.

Authors:  Yi Kan Wang; Cristin G Print; Edmund J Crampin
Journal:  BMC Genomics       Date:  2013-02-13       Impact factor: 3.969

8.  Survival analysis by penalized regression and matrix factorization.

Authors:  Yeuntyng Lai; Morihiro Hayashida; Tatsuya Akutsu
Journal:  ScientificWorldJournal       Date:  2013-04-23

9.  SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis.

Authors:  Raul Aguirre-Gamboa; Hugo Gomez-Rueda; Emmanuel Martínez-Ledesma; Antonio Martínez-Torteya; Rafael Chacolla-Huaringa; Alberto Rodriguez-Barrientos; José G Tamez-Peña; Victor Treviño
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.